ADVANCEMENTS IN HAEMATO ONCOLOGY TREATMENT AT SAMMPRADA MULTI- SPECIALITY HOSPITAL

1
ADVANCEMENTS IN HAEMATO ONCOLOGY TREATMENT AT
SAMMPRADA MULTI- SPECIALITY HOSPITAL
2
INTRODUCTION
Welcome to the presentation on Advancements in
Haemato Oncology Treatment at Sammprada
Multi-Speciality Hospital. In this presentation,
we will explore the latest breakthroughs and
cutting-edge technologies in the ?eld of haemato
oncology. We will discuss the impact of these
advancements on patient care and outcomes. Let's
dive in!
3
IMMUNOTHERAPY IN HAEMATO ONCOLOGY
Immunotherapy harnesses the power of the immune
system to ?ght cancer. It stimulates the body's
immune response to recognize and destroy cancer
cells. In haemato oncology, CAR-T cell therapy
has emerged as a breakthrough treatment. It
involves modifying a patient's own immune cells
to recognize and attack cancer cells.
Immunotherapy has shown remarkable success in
treating certain types of blood cancers.
4
PRECISION MEDICINE IN HAEMATO ONCOLOGY Precision
medicine is a personalized approach to treating
cancer based on an individual's unique genetic
makeup. In haemato oncology, precision medicine
has led to the development of molecularly
targeted therapies. These drugs speci?cally
target genetic mutations or alterations in
cancer cells, leading to more effective and less
toxic treatments. The use of precision medicine
has transformed the landscape of haemato
oncology treatment.
5
IMMUNOTHERAPY IN HAEMATO ONCOLOGY
Immunotherapy harnesses the power of the immune
system to ?ght cancer. It stimulates the body's
immune response to recognize and destroy cancer
cells. In haemato oncology, CAR-T cell therapy
has emerged as a breakthrough treatment. It
involves modifying a patient's own immune cells
to recognize and attack cancer cells.
Immunotherapy has shown remarkable success in
treating certain types of blood cancers.
6
Stem cell transplantation is a crucial treatment
option for many haemato oncology patients.
Recent advancements in stem cell transplantation
techniques have improved outcomes and reduced
complications. Haploidentical transplantation has
emerged as a viable alternative when a fully
matched donor is not available. Additionally,
advancements in graft-versus- host disease
prevention have enhanced the success rate of
stem cell transplantation.
7
CONCLUSION
The advancements in haemato oncology treatment at
Sammprada Multi- Speciality Hospital have
revolutionized patient care. Precision medicine,
immunotherapy, and stem cell transplantation
techniques have signi?cantly improved outcomes
for blood cancer patients. These breakthroughs
offer hope and a brighter future for individuals
battling haemato oncology diseases. Sammprada
Multi-Speciality Hospital remains committed to
staying at the forefront of innovation in haemato
oncology.
8
Thanks!
Do you have any questions? 8884703308 /
7760396162 info_at_sammprada.com www.sammprada.com